Integration of genomic and non-genomic steroid receptor actions
New insights on the role of hormonal therapy in ovarian cancer
Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment
The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific
Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression
PGRMC2, a yet uncharacterized protein with potential as tumor suppressor, migration inhibitor, and regulator of cytochrome P450 enzyme activity
Progestin drives breast cancer growth by inducing p21CIP1 expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2
Invasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systems ☆
Lessons from the dissection of the activation functions (AF-1 and AF-2) of the estrogen receptor alpha in vivo
Protective actions of progesterone in the cardiovascular system: Potential role of membrane progesterone receptors (mPRs) in mediating rapid effects
Emerging evidence of the importance of rapid, non-nuclear estrogen receptor signaling in the cardiovascular system
Neuroprotective action of acute estrogens: Animal models of brain ischemia and clinical implications
Membrane-initiated estradiol signaling in immortalized hypothalamic N-38 neurons
Estrogen regulation of spine density and excitatory synapses in rat prefrontal and somatosensory cerebral cortex
Long-term estrogen deprivation leads to elevation of Dickkopf-1 and dysregulation of Wnt/β-Catenin signaling in hippocampal CA1 neurons
Membrane receptor cross talk in steroidogenesis: Recent insights and clinical implications